Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Ashley M. Henneghan(The University of Texas at Austin), Shelli R. Kesler(The University of Texas at Austin), Cobi J. Heijnen(Rice University), Tara Kaufmann(The University of Texas at Austin), Kathleen Van Dyk(University of California, Los Angeles), Rebecca A. Harrison(BC Cancer Agency), Christopher Gibbons(The University of Texas MD Anderson Cancer Center)
Cited by 115
Related Papers
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
|Nature Medicine|2023|372
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
|Frontiers in Psychology|2022|87
Disrupted brain network functional dynamics and hyper‐correlation of structural and functional connectome topology in patients with breast cancer prior to treatment
|Brain and Behavior|2017|78
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
|Acta Neuropathologica Communications|2018|78
Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review
|Supportive Care in Cancer|2015|62